Ly6g6d - lymphocyte antigen 6 complex, locus G6D Gene

Also Known as G6d; G6f; NG25; NG32; MEGT1; g6f-ly6g6d; A930024F17Rik

Species: Mus musculus

Gene Type: protein coding
Gene ID: 114654

Summary

Enables acetylcholine receptor inhibitor activity and identical protein binding activity. Acts upstream of or within acetylcholine receptor signaling pathway. Part of protein-containing complex. Colocalizes with external side of plasma membrane. Is expressed in brain; embryo; lung; and metanephros. Orthologous to human LY6G6D (lymphocyte antigen 6 family member G6D). [provided by Alliance of Genome Resources, Apr 2022]

Ly6g6d Products (3)

mRNA Protein Name
NM_001371027.1 NP_001357956.1 lymphocyte antigen 6 complex locus protein G6d isoform 2
NM_001371028.1 NP_001357957.1 lymphocyte antigen 6 complex locus protein G6d isoform 3
NM_033478.3 NP_258439.1 lymphocyte antigen 6 complex locus protein G6d isoform 1 precursor

Gene Ontology

  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence References Source
enables acetylcholine receptor inhibitor activity IDA
IDA: Inferred from direct assay
26276394 MGI
enables identical protein binding IDA
IDA: Inferred from direct assay
17008713 MGI
Biological Process GO Annotation Evidence References Source
acts upstream of or within acetylcholine receptor signaling pathway IDA
IDA: Inferred from direct assay
26276394 MGI
Cellular Component GO Annotation Evidence References Source
colocalizes with external side of plasma membrane IDA
IDA: Inferred from direct assay
17008713 MGI
part of protein-containing complex IDA
IDA: Inferred from direct assay
17008713 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

lymphocyte antigen 6 complex locus protein G6d

  • megakaryocyte-enhanced gene transcript 1

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P990925 Linclatamig Inhibitor 97.04% Phase 1

Pre-clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-RS07899 LY6G6D Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS07900 LY6G6F Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS19787 Ly6g6d Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26283 Ly6g6d Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Ly6g6d NCBI NCBI:58530